Successful surgical treatment of primary synchronous multiple cancer of the stomach and gallbladder

Gastric cancer is among the most common malignant diseases and ranks fifth in incidence and mortality worldwide according to GLOBOCAN 2022. Gallbladder cancer is significantly less prevalent, ranking 22nd in terms of incidence, with 122 000 new cases reported in 2022. The synchronous occurrence of these malignancies is exceptionally rare. The global literature describes only a limited number of cases addressing therapeutic approaches in patients with synchronous gastric and gallbladder cancers. The present report describes a patient diagnosed with synchronous multiple primary malignancies of the stomach and gallbladder. A comprehensive diagnostic assessment, including endoscopy, histopathological verification, and imaging studies, enabled characterization of the disease and determination of the treatment strategy. The patient received perioperative systemic therapy using the FLOT regimen, followed by gastrectomy with lymph node dissection and cholecystectomy. Systemic therapy was subsequently continued in the adjuvant setting. During follow-up, no signs of disease recurrence were detected. This case highlights the importance of differential diagnosis between primary tumors and metastatic lesions, and underscores the necessity of a multidisciplinary approach when determining treatment strategies for patients with rare combinations of synchronous oncological diseases.

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. https://doi.org/10.3322/caac.21834.

2. Zhou S, Lu Z, Wu H, Gu CY, Zhang DY, Sun WL et al. Synchronous multiple primary gallbladder and gastric malignancies: report of two cases and review of the literature. Mol Clin Oncol. 2017;7(5):869–873. https://doi.org/10.3892/mco.2017.1397.

3. Nguyen MT, Dang CT, Nguyen THT, Ngo QT, Pham AV. Synchronous tumors of gastric carcinoma combined gallbladder cancer and pseudotumor chronic pancreatitis. Int J Surg Case Rep. 2024;116:109344. https://doi.org/10.1016/j.ijscr.2024.109344.

4. Tamura M, Shinagawa M, Funaki Y. Synchronous triple early cancers occurring in the stomach, colon and gallbladder. Asian J Surg. 2003;26(1):46–48. https://doi.org/10.1016/S1015-9584(09)60216-5.

5. Dalgıç T, Öter V, Koşmaz K, Özer İ, Bostancı EB. Synchronous double primary malignant tumor of the remnant stomach and gallbladder: a case report. CausaPedia. 2015;4:1144. Available at: https://www.semanticscholar.org/paper/Synchronous-Double-Primary-Malignant-Tumor-of-the-A-CerrahiÖter/18721c1413dfb6b39da84dafaca4abd4b476ee9c.

6. Kawamoto A, Kimura K, Hirose K, Izumi T, Taniguchi D, Yano H et al. Synchronous gallbladder metastasis originating from residual gastric cancer: a case report and review of the literature. Surg Case Rep. 2022;8:88. https://doi.org/10.1186/s40792-022-01442-5.

7. Warren S. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer. 1932;16:1358–1414. Available at: https://www.semanticscholar.org/paper/Multiple-primary-malignant-tumors.-A-survey-of-the-Warren/db002e714d10e5dd14b81934601ddfbe2697c060.

8. La Rosa S, Sessa F, Uccella S. Mixed neuroendocrine–nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms. Endocr Pathol. 2016;27(4):284–311. https://doi.org/10.1007/s12022-016-9432-9.

9. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1–25. https://doi.org/10.1007/s10120-022-01331-8.

10. Besova NS, Bolotina LV, Gamayunov SV, Kalinin AE, Kozlov NA, Malikhova OA et al. Practical recommendations for systemic therapy of gastric cancer. Practical recommendations of the Russian Society of Clinical Oncology (RUSSCO), part 1. Malignant Tumors. 2023;13(3s2):405–424. (In Russ.) https://doi.org/10.18027/2224-5057-2023-13-3s2-1-405-424.

11. Besova NS, Tryakin AA, Artamonova EV, Bolotina LV, Kalinin AE, Kononets PV et al. Practical recommendations for drug treatment of gastric cancer. Malignant Tumors. 2020;10(3s2-1):334–349. (In Russ.) https://doi.org/10.18027/2224-5057-2020-10-3s2-21.

12. Toneev EA, Martynov AA, Anokhina EP, Ponomarenko AM, Romanova ON. A clinical case of successful treatment of stage IV gastric cancer. P.A. Herzen Journal of Oncology. 2024;13(5):54–58. (In Russ.) https://doi.org/10.17116/onkolog20241305154.

13. Skoropad VYu, Mironova DYu, Kudryavtsev DD, Smolenov EI, Kolobaev IV, Ivanov SA et al. Long-term clinical outcomes of patients with locally advanced gastric adenocarcinoma after two induction cycles of chemotherapy according to the FLOT regimen followed by chemoradiotherapy and radical surgery. P.A. Herzen Journal of Oncology. 2025;14(2):5–12. (In Russ.) https://doi.org/10.17116/onkolog2025140215.

14. Breder VV, Bazin IS, Balakhnin PV, Virshke ER, Kosyrev VY, Ledin EV et al. Practical recommendations for the drug treatment of malignant tumors of the liver and biliary system. Malignant Tumors. 2022;12(3s2-1):467–529. (In Russ.) https://doi.org/10.18027/2224-5057-2022-12-3s2-467-529.

15. Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Chow S, Knox JJ et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol. 2019;37(12):1015–1027. https://doi.org/10.1200/JCO.18.02178.

16. Anokhina EP, Toneev EA, Zaripov LR, Martynov AA, Shagdaleev RF, Ulyanova UA, Minacheva AD. Clinical and Morphological Indicators of Early Gastric Cancer Recurrence. Int J Bio. 2025;15(3):500–504. https://doi.org/10.21103/Article15(3)_OA6.

17. Primrose JN, Fox RP, Palmer DH, Prasad R, Mirza D, Anthony A et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663–673. https://doi.org/10.1016/S1470-2045(18)30915-X.

18. Toneev EA, Keshyan EA, Nuretdinov DI, Martynov AA, Zhynov AV, Firstov AA. Analysis of the frequency and risk indicators of developing acute pancreatitis after gastrectomy. Vestnik Khirurgii Imeni I.I. Grekova. 2025;184(4):34–40. (In Russ.) https://doi.org/10.24884/0042-4625-2025-184-4-34-40.

19. Toneev EA, Keshyan EA, Nuretdinov DI, Martynov AA, Zhinov AV, Shagdaleev RF. Pancreatic fistula after gastrectomy. Retrospective single-center analysis. Siberian Journal of Oncology. 2024;23(4):108–116. (In Russ.) https://doi.org/10.21294/1814-4861-2024-23-4-108-116.

20. Toneev EA, Firstov AA, Keshyan EA, Pikin OV, Danilova LA, Martynov AA, Zhinov AV. Early surgical outcomes of gastrectomies for gastric cancer: experience of a regional oncology center. Novosti Khirurgii. 2023;31(6):502–512. (In Russ.) Available at: https://surgery.by/list.php?&lang=ru&year=2023&issue=6.